OR WAIT null SECS
This new pharmaceutical stability storage facility will enable the company to expand its analytical and formulation offerings to the pharmaceutical and biotech industries.
Intertek has opened a new 8000-square-feet, 190,000-liter pharmaceutical stability storage facility in Royston, United Kingdom. This new GMP-compliant facility will enable the company to expand its analytical and formulation offerings to the pharmaceutical and biotech industries. As part of Intertek’s wider investment program in global pharmaceutical capabilities, it also complements the company’s existing product development services for pharmaceuticals, biologics, medical devices, as well as other sectors such as consumer healthcare and nutraceuticals.
This new pharmaceutical stability storage facility increases Intertek’s stability storage capacity and will enable clients to establish recommended storage conditions with a state-of-the-art environmental monitoring system. Mark Hammond, laboratory director, commented in a press statement, that “this new facility, integrated with our scientists’ experience and knowledge of pharmaceutical testing, will bring a range of storage solutions with options for client bespoke conditions and risk management storage to meet the increased demands from our global clients.”
GMP stability testing is a key part of Intertek’s pharmaceutical development services. Intertek’s global International Conference on Harmonization (ICH) stability storage and testing locations also include Manchester (UK), Whitehouse, (New Jersey, US), and Melbourne (Australia).